Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB06414_DB08875> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB06414_DB08875 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB06414_DB08875 label "DDI between Etravirine and Cabozantinib - Cabozantinib, when used concomitantly with etravirine, may experience a decrease in serum concentration. It is recommended to avoid this combination if alternative are available. If concurrent use is not avoidable, it is recommended to increase the dosage of cabozantinib by 40mg (without exceeding 180mg/day). [drugbank_resource:DB06414_DB08875]" assertion.
- drugbank_resource:DB06414_DB08875 identifier "drugbank_resource:DB06414_DB08875" assertion.
- drugbank_resource:DB06414_DB08875 title "DDI between Etravirine and Cabozantinib - Cabozantinib, when used concomitantly with etravirine, may experience a decrease in serum concentration. It is recommended to avoid this combination if alternative are available. If concurrent use is not avoidable, it is recommended to increase the dosage of cabozantinib by 40mg (without exceeding 180mg/day)." assertion.